Labcorp Holdings Inc.

LH · Medical Laboratories · $26.0B
Powering up
LH
$320.71
▼ −0.63%
09/18 O 322.00 H 322.70 L 319.38 C 320.71 ▼ −0.63%
Vol 1.7M RS 71
RS rating71
Now vs pivot (%)−6.17%
Tightening (ATR ratio)0.74×
Volume dry-up0.64×
Up/down volume, net0.04
From 52-week high6%
forming
Powering up
Moving averages
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year

The four are not in order. That is a description of where the averages sit, not a view about what happens next.

The read

The base has run 3.2 weeks and fell 11% from its ceiling at its deepest. The pivot is $341.80, and the stock closed 6.2% below it. Its relative strength rating is 71.

Peers
Same theme
No themes — common and fine.
Catalyst roadmap
  1. Earningstentativein 39d
    Quarterly earnings
    Oct 27, 2026
Flagged by the market sweep

Nothing flagged for this company on the last market sweep.

In the news
Global Pathology Services Market to Reach $307.9 Billion by 2030, Driven by Rising Cancer Incidence and AI-Enabled Diagnostic InnovationGlobeNewswire Inc. · 2026-08-31

Headlines link to the publisher. We do not host, summarise or rank them, and a headline appearing here is not a view about the company.

Insiders

No Form 4 filings read for this company in the last six months. That can mean nobody filed, or that this name has not been on a screen long enough for us to have fetched them.

X-ray

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. Historical figures are backtests and are hypothetical.

What that means, in full
Labcorp Holdings Inc. (LH) — The Tape